固体瘤免疫治疗中的调控性T细胞:作用,机制和临床应用
Yan Pan1,2, Hanqiong Zhou1,2, Zhenqiang Sun3
1Department of Internal Medicine, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Cell death & disease
|April 11, 2025
概括
调节性T细胞抑制抗瘤免疫力,帮助瘤进展. 在固体瘤中准这些细胞为增强癌症免疫治疗结果提供了一个有希望的途径.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症研究 癌症研究
背景情况:
- 瘤发生涉及瘤细胞和免疫系统之间的复杂相互作用.
- 调节性T细胞 (Tregs) 对免疫平衡至关重要,但可以矛盾地促进瘤生长.
- 固体瘤对有效的抗瘤免疫反应提出了独特的挑战.
研究的目的:
- 审查调节性T细胞在固体瘤免疫治疗中的多方面的作用.
- 探索Tregs如何影响固体瘤的预后和免疫微环境重塑.
- 总结目前的临床应用和Treg向固体瘤治疗的未来方向.
主要方法:
- 文献综述侧重于固体瘤免疫学中的调节性T细胞.
- 对Treg功能与瘤进展和免疫规避有关的分析.
- 检查临床试验数据和涉及Tregs的治疗策略.
主要成果:
- 调节性T细胞在血液性恶性瘤中比固体瘤更为普遍和成熟.
- 以Treg为媒介的免疫抑制可以显著阻碍固体瘤中的抗瘤免疫反应.
- 向Tregs显示了改善固体瘤免疫疗法疗效的潜力.
结论:
- 了解Treg机制对于推进固体瘤免疫治疗至关重要.
- 调节Treg活性可以克服免疫抵抗并改善患者的预后.
- 需要进一步的研究和临床试验来优化基于Treg的治疗策略.
相关概念视频
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
T Cell Activation and Clonal Selection
548
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
548
T Cell Types and Functions
638
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
638
Cytotoxic T Cells-mediated Immune Response
737
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
737
Tumor Immunotherapy
406
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
406


